304 related articles for article (PubMed ID: 8521397)
1. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma.
Feitelson MA; Zhu M; Duan LX; London WT
Oncogene; 1993 May; 8(5):1109-17. PubMed ID: 8386823
[TBL] [Abstract][Full Text] [Related]
3. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
Slagle BL; Zhou YZ; Butel JS
Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
[TBL] [Abstract][Full Text] [Related]
5. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
Lin J; Zhu MH; Qu JH; Li FM; Ni CR
Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus and hepatocellular carcinoma: a possible role for the viral transactivators.
Levrero M; Balsano C; Avantaggiati ML; Natoli G; De Marzio E; Will H
Ital J Gastroenterol; 1991 Dec; 23(9):576-83. PubMed ID: 1662093
[TBL] [Abstract][Full Text] [Related]
7. HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells.
Qu J; Lin J; Zhang S; Zhu Z; Ni C; Zhang S; Gao H; Zhu M
Biochem Biophys Res Commun; 2009 Aug; 386(3):504-9. PubMed ID: 19540192
[TBL] [Abstract][Full Text] [Related]
8. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis B X antigen binding to p53 protein in the pathogenesis of primary hepatocellular carcinoma].
Zhu MH
Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):325-8, 379. PubMed ID: 8258098
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
12. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
13. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
14. [The determination of the viral markers of the hepatitis B virus and protein p53 in liver biopsy samples].
Lörinczi L; Székely E
Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):161-6. PubMed ID: 9932005
[TBL] [Abstract][Full Text] [Related]
15. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.
Puisieux A; Ponchel F; Ozturk M
Oncogene; 1993 Feb; 8(2):487-90. PubMed ID: 8381223
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
17. [Interaction effect of p53 with HBV in hepatoma cell line SMMC-7721].
Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):403-5. PubMed ID: 15268803
[TBL] [Abstract][Full Text] [Related]
18. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
[TBL] [Abstract][Full Text] [Related]
19. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
20. Viral co-factors in liver cancer: lessons from hepatitis B virus.
Butel JS; Lee TH; Slagle BL
Princess Takamatsu Symp; 1995; 25():185-98. PubMed ID: 8875624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
